Diabetica Ltd was established in September 2004 to commercialise discoveries at the Diabetes Research Group in the University of Ulster, under the leadership of scientific co-founders Prof Peter Flatt, Dr Neville McClenaghan and Prof Finbarr O'Harte.

Diabetica's primary business is the development of novel therapeutics, diagnostic and other innovative technologies in the areas of type 2 diabetes, obesity and metabolic syndrome.

Further information regarding Diabetica can be found under the following links: